A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Stimulants
This training provides a foundational overview of contingency management (CM) as an evidence-based intervention for substance use disorders. Participants will learn to recognize the seven core principles of CM, identify at least two effective implementation strategies, and understand the critical role of monitoring and auditing to prevent waste, fraud, and abuse. The session will also highlight at least three substance use disorders for which CM is a proven treatment approach. Designed for clinicians, program managers, and support staff, this training equips participants with practical tools to apply CM with fidelity and accountability in diverse treatment settings.
![]() |
Thursday, 7/16/2026 1:00 pm – 2:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training provides healthcare providers with advanced knowledge and practical skills to deliver high-quality, patient-centered treatment plans for individuals on buprenorphine for opioid use disorder (OUD). Participants will enhance their confidence in buprenorphine initiation through real-world case studies, exploring low-barrier models of care to improve access for individuals with OUD and strategies to reduce the risk of precipitated withdrawal.
![]() |
Friday, 7/17/2026 1:00 pm – 3:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: CARN and CARN-AP
This training is meant for Registered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) working in the addiction field who are interested in becoming Certified Addictions Registered Nurse (CARN) or a Certified Addictions Registered Nurse - Advanced Practice (CARN-AP). The course is intended to support nurses studying for the certification exam by reviewing content covered in the exam and providing additional educational resources relevant to the exam.
![]() |
Monday, 7/20/2026 11:00 am – 2:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) with experience treating patients with addiction who intend to sit for the CARN or CARN-AP exam. |
Topic: CARN and CARN-AP
This training is meant for Registered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) working in the addiction field who are interested in becoming Certified Addictions Registered Nurse (CARN) or a Certified Addictions Registered Nurse - Advanced Practice (CARN-AP). The course is intended to support nurses studying for the certification exam by reviewing content covered in the exam and providing additional educational resources relevant to the exam.
![]() |
Monday, 7/27/2026 11:00 am – 2:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) with experience treating patients with addiction who intend to sit for the CARN or CARN-AP exam. |
Topic: Stimulants
This training is a guide for addiction care teams caring for people who use stimulants, including cocaine and methamphetamines. The training will review the basic science of addiction related to stimulants and discuss the practical implementation of evidence-based treatment for patients who use stimulants, with a concentration on outpatient treatment settings.
![]() |
Monday, 8/3/2026 1:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Allyson Pinkhover, MPH, will recognize the utility of drug supply testing in a community health setting and consider barriers and strategies for integrating drug supply testing. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 8/4/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Charmaine Lastimoso, MSN, NP-C, MPH, CARN-AP, will describe the relationship between substance use disorders and brain injuries. She will also recognize the impact of brain injury on fundamental cognitive skills and identify screening and treatment needs for patients with brain injury. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 9/1/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |
Topic: Buprenorphine
This training is designed to provide foundational knowledge and skills in initiating buprenorphine treatment for opioid use disorder in the outpatient setting in the context of the widespread presence of illicitly manufactured fentanyl. We explore how the potency and prevalence of fentanyl complicates the initiation phase of buprenorphine treatment, leading to potential clinical challenges such as precipitated withdrawal. We suggest participating in the next training in the series, Buprenorphine 201, upon completing Buprenorphine 101.
![]() |
Tuesday, 9/15/2026 3:00 pm – 4:00 pm ET |
![]() |
This training fulfills the DEA's 8-hour training requirement for prescribers |
![]() |
Virtual event |
![]() |
Intended AudienceMedical providers (physicians, advanced practice providers), nurses, and other clinical team members that support medical management of opioid use disorder. |
Topic: CARN and CARN-AP
This training is meant for Registered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) working in the addiction field who are interested in becoming Certified Addictions Registered Nurse (CARN) or a Certified Addictions Registered Nurse - Advanced Practice (CARN-AP). The course is intended to support nurses studying for the certification exam by reviewing content covered in the exam and providing additional educational resources relevant to the exam.
![]() |
Tuesday, 9/15/2026 4:00 pm – 7:00 pm ET |
![]() |
Virtual event |
![]() |
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs) with experience treating patients with addiction who intend to sit for the CARN or CARN-AP exam. |
Topic: ECHO
As part of the twice-monthly MA OBAT ECHO® series, Megan Gerber, MD, MPH, FACP, will describe core principles of trauma-informed care and apply them to the assessment and treatment of individuals with substance use disorders across clinical settings. She will also identify practical, trauma-informed strategies to reduce re-traumatization, enhance patient engagement, and support recovery-oriented care for people with SUD. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.
![]() |
Tuesday, 9/22/2026 7:30 am – 9:00 am ET |
![]() |
Virtual event |
![]() |
Intended AudienceProviders, nurses, social workers, psychologists, peer supports, other clinical staff, and non-clinicians. |